Saeed Katiraei

Mr. Saeed Katiraei


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in European Journal of Pharmacology
Verified
Journal Article
Open access
LPLaura Parma
Laura Parma
FBFabiana Baganha
Fabiana Baganha
Paul QuaxPaul Quax
Paul Quax
Margreet de VriesMargreet de Vries
Margreet de Vries
Acute cardiovascular events, due to rupture or erosion of an atherosclerotic plaque, represent the major cause of morbidity and mortality in patients. Growing evidence suggests that plaque neovascularization is an important contributor to plaque growth and instability. The vessels' immaturity, with profound structural and functional abnormalities, leads to recurrent intraplaque hemorrhage. This review discusses new insights of atherosclerotic neovascularization, including the effects of leaky neovessels on intraplaque hemorrhage, both in experimental models and humans. Furthermore, modalities for in vivo imaging and therapeutic interventions to target plaque angiogenesis will be discussed.

24 March 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
TSThijs Sluiter
Thijs Sluiter
Jaap van BuulJaap van Buul
Jaap van Buul
SHStephan Huveneers
Stephan Huveneers
Paul QuaxPaul Quax
Paul Quax
Margreet de VriesMargreet de Vries
Margreet de Vries
The vascular endothelium is a highly specialized barrier that controls passage of fluids and migration of cells from the lumen into the vessel wall. Endothelial cells assist leukocytes to extravasate and despite the variety in the specific mechanisms utilized by different leukocytes to cross different vascular beds, there is a general principle of capture, rolling, slow rolling, arrest, crawling, and ultimately diapedesis via a paracellular or transcellular route. In atherosclerosis, the barrier function of the endothelium is impaired leading to uncontrolled leukocyte extravasation and vascular leakage. This is also observed in the neovessels that grow into the atherosclerotic plaque leading to intraplaque hemorrhage and plaque destabilization. This review focuses on the vascular endothelial barrier function and the interaction between endothelial cells and leukocytes during transmigration. We will discuss the role of endothelial dysfunction, transendothelial migration of leukocytes and plaque angiogenesis in atherosclerosis.

24 January 2018 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
Margreet de VriesMargreet de Vries
Margreet de Vries
Paul QuaxPaul Quax
Paul Quax
Bypass surgery is one of the most frequently used strategies to revascularize tissues downstream occlusive atherosclerotic lesions. For venous bypass surgery the great saphenous vein is the most commonly used vessel. Unfortunately, graft efficacy is low due to the development of vascular inflammation, intimal hyperplasia and accelerated atherosclerosis. Moreover, failure of grafts leads to significant adverse outcomes and even mortality. The last couple of decades not much has changed in the treatment of vein graft disease (VGD). However, insight is the cellular and molecular mechanisms of VGD has increased. In this review, we discuss the latest insights on VGD and the role of inflammation in this. We discuss vein graft pathophysiology including hemodynamic changes, the role of vessel wall constitutions and vascular remodeling. We show that profound systemic and local inflammatory responses, including inflammation of the perivascular fat, involve both the innate and adaptive immune system.

15 February 2019 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
KSKarin H. Simons
Karin H. Simons
AJAlwin de Jong
Alwin de Jong
JJJ. Wouter Jukema
J. Wouter Jukema
Margreet de VriesMargreet de Vries
Margreet de Vries
RARamon Arens
Ramon Arens
Paul QuaxPaul Quax
Paul Quax

6 August 2019 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
SKSaeed Katiraei
Saeed Katiraei
MVMargreet R. de Vries
Margreet R. de Vries
ACAlice H. Costain
Alice H. Costain
KTKathrin Thiem
Kathrin Thiem
LHLisa R. Hoving
Lisa R. Hoving
VHVanessa van Harmelen
Vanessa van Harmelen
Scope: Akkermansia muciniphila (A. muciniphila) is an intestinal commensal with anti‐inflammatory properties both in the intestine and other organs. The aim is to investigate the effects of oral administration of A. muciniphila on lipid metabolism, immunity, and cuff‐induced neointima formation in hyperlipidemic APOE*3‐Leiden (E3L).CETP mice.Methods and results: Hyperlipidemic male E3L.CETP mice are daily treated with 2 × 108 CFU A. muciniphila by oral gavage for 4 weeks and the effects are determined on plasma lipid levels, immune parameters, and cuff‐induced neointima formation and composition. A. muciniphila administration lowers body weight and plasma total cholesterol and triglycerides levels. A. muciniphila influences the immune cell composition in mesenteric lymph nodes, as evident from an increased total B cell population, while reducing the total T cell and neutrophil populations. Importantly, A. muciniphila reduces the expression of the activation markers MHCII on dendritic cells and CD86 on B cells. A. muciniphila also increases whole blood ex vivo lipopolysaccharide‐stimulated IL‐10 release. Finally, although treatment with A. muciniphila improves lipid metabolism and immunity, it does not affect neointima formation or composition.Conclusions: Four weeks of treatment with A. muciniphila exerts lipid‐lowering and immunomodulatory effects, which are insufficient to inhibit neointima formation in hyperlipidemic E3L.CETP mice.

10 October 2019 in Journal of Pineal Research
Verified
Journal Article
Open access
PDF file
MSMaaike Schilperoort
Maaike Schilperoort
RBRosa van Den Berg
Rosa van Den Berg
LBLaura A. Bosmans
Laura A. Bosmans
BOBram W. van Os
Bram W. van Os
MDMartijn E. T. Dollé
Martijn E. T. Dollé
SKSander Kooijman
Sander Kooijman
Disruption of circadian rhythm by means of shift work has been associated with cardiovascular disease in humans. However, causality and underlying mechanisms have not yet been established. In this study, we exposed hyperlipidemic APOE*3‐Leiden.CETP mice to either regular light‐dark cycles, weekly 6 hours phase advances or delays, or weekly alternating light‐dark cycles (12 hours shifts), as a well‐established model for shift work. We found that mice exposed to 15 weeks of alternating light‐dark cycles displayed a striking increase in atherosclerosis, with an approximately twofold increase in lesion size and severity, while mice exposed to phase advances and delays showed a milder circadian disruption and no significant effect on atherosclerosis development. We observed a higher lesion macrophage content in mice exposed to alternating light‐dark cycles without obvious changes in plasma lipids, suggesting involvement of the immune system. Moreover, while no changes in the number or activation status of circulating monocytes and other immune cells were observed, we identified increased markers for inflammation, oxidative stress, and chemoattraction in the vessel wall. Altogether, this is the first study to show that circadian disruption by shifting light‐dark cycles directly aggravates atherosclerosis development.